2026 Annual General Meeting - MD & CEO's Address
Filed with ASX · · 27 pages · English
Earlier from Atomo Diagnostics
- Chair's Address to Shareholders
- Change in substantial holding
- Q1 FY27 Results Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Atomo Signs Agreement with Innovation Scientific
Later from Atomo Diagnostics
All Atomo Diagnostics news releasesFollow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics